Logo 8 3688
Pill imprint Logo 8 3688 has been identified as Doxazosin mesylate 8 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy.
Doxazosin 8 mg is not subject to the Controlled Substances Act.
See also related documents.
Doxazosin mesylate Images
- Imprint:
-
Logo 8
3688 - Strength:
- 8 mg
- Color:
- Green
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
D&C Yellow No. 10 Aluminium Lake
FD&C Blue No. 1 Aluminium Lake
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-3688
Advertisement
More Doxazosin Mesylate resources
- Doxazosin
- Doxazosin (Wolters Kluwer)
- Doxazosin Extended-Release Tablets (Wolters Kluwer)
- doxazosin (Cerner Multum)
- doxazosin (Micromedex) - Includes Dosage Information
- Doxazosin Mesylate (AHFS DI)
- Doxazosin (FDA)
- Doxazosin Mesylate (Wolters Kluwer)
Search Again
